Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

GSK3640254 is a next‐generation maturation inhibitor with demonstrated potency across HIV‐1 subtypes and a high barrier to emergent resistance. This phase I, 2‐part, randomized, open‐label study (ClinicalTrials.gov identifier, NCT04263142) in healthy participants assessed the relative bioavailabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Mark, Pene Dumitrescu, Teodora, Joshi, Samit R., Mathew, Ashwin, Bainbridge, Veronica, Zhan, Joyce, Lataillade, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306620/
https://www.ncbi.nlm.nih.gov/pubmed/34995417
http://dx.doi.org/10.1002/cpdd.1051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306620/
https://www.ncbi.nlm.nih.gov/pubmed/34995417
http://dx.doi.org/10.1002/cpdd.1051

Ejemplares similares